Christopher Ede

Christopher Ede is a highly experienced scientist specializing in genetics and molecular biology. Currently serving as a Variant Scientist at Cedars-Sinai since August 2024, Christopher Ede previously held the position of Senior Genetic Curation Scientist at Fulgent Genetics from February 2017 to August 2024. Prior roles include Postdoctoral Researcher at UCLA, focusing on receptor-dependent cancer therapeutics, and Postdoctoral Fellow positions at Caltech and UC Davis, where research centered on DNA damage response and yeast helicase function, respectively. Christopher Ede obtained a Dr. rer. nat. in Molecular Genetics and a Dipl. Biol. in Biology from the University of Göttingen.